Open AccessMetronidazole vaginal gel 0.75% (MetroGel‐Vaginal®): A brief review
Author(s) -
Wain A.M.
Publication year - 1998
Publication title -
infectious diseases in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.656
H-Index - 48
eISSN - 1098-0997
pISSN - 1064-7449
DOI - 10.1002/(sici)1098-0997(1998)6:1<3::aid-idog2>3.0.co;2-0
Subject(s) - obstetrics and gynaecology , mount , medicine , psychology , library science , engineering , pregnancy , computer science , mechanical engineering , genetics , biology
etronidazole vaginal gel 0.75% (MetroGelVaginal(R), 3M Pharmaceuticals, St. Paul, MN) is the intravaginal form of the antibacterial, antiprotozoal agent metronidazole. MetroGel-Vaginal is indicated for the treatment of bacterial vaginosis (BV) and has been shown to be as effective as the oral form of metronidazole for this condition. Recently, a single daily five-day dosing regimen was approved by the Food and Drug Administration.z The prior dosing regimen was twice daily for five days.The current product labeling allows for either dosing regimen to be used.